According to a filing with the U.S. Securities and Exchange Commission, the company is selling up to 19.56 million shares of VLCN stock in this offering. Investors will also note that the assumed price for shares in this offering is 92 cents apiece.
Volcon notes that each share in this offering also comes with 0.35 warrants. These warrants will allow holders to purchase one additional share of VLCN stock.
What This Means for VLCN Stockholders
Investors don’t often react well to news of a public offering and that’s holding true today. As of this writing, more than 246,000 shares of VLCN stock are changing hands alongside the news. For the record, the company’s daily average trading volume is about 64,000 shares.
Oftentimes, the low offering price upsets investors. They also don’t like the increase in outstanding shares, which dilutes their current stakes in the company.
VLCN stock is down 36.5% as of Thursday morning.
Investors looking for more of the most recent stock market news will want to keep reading!
InvestorPlace is home to all of the hottest stock market happenings worth reading about on Thursday. A few examples include why shares of Flora Growth (NASDAQ:FLGC) and Bone Biologics (NASDAQ:BBLG) stock are up today, as well as a dive into the biggest pre-market stock movers this morning. All of that news is available at the following links!
More Thursday Stock Market News
- Why Is Flora Growth (FLGC) Stock Up 7% Today?
- Why Is Bone Biologics (BBLG) Stock Up 84% Today?
- Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com’s writers disclose this fact and warn readers of the risks.
On the date of publication, William White did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.